Cibus Inc
CBUS1.525USD
+0.035+2.35%
交易中 （美东）报价延迟15分钟
49.80M总市值
亏损市盈率 TTM
关于 Cibus Inc 公司
Cibus, Inc. 是一家农业技术公司，利用基因编辑技术开发种子中的植物性状。其业务是开发有助于解决农业中特定生产力或产量挑战的植物性状，例如解决植物农学、疾病、昆虫、杂草、营养利用或气候的性状。该公司还致力于开发某些替代植物油或生物基发酵产品。其技术是其基因编辑平台，称为快速性状开发系统 (RTDS)。它是该公司 Trait Machine 流程的基础技术，这是一种端到端半自动化高通量基因编辑系统，可直接编辑种子公司的精英种质。它有五种生产力性状，其中四种适用于多种作物。这些性状是油菜中的 PSR 和水稻中的 HT1 和 HT3。此外，它还具有两种抗菌核病的高级性状和另一种新型阔叶 HT 性状 HT2。
公司简介
公司代码CBUS
公司名称Cibus Inc
上市日期Jul 20, 2017
CEODr. Peter Ronald Beetham, Ph.D.
员工数量157
证券类型Ordinary Share
年结日Jul 20
公司地址6455 Nancy Ridge Drive
城市SAN DIEGO
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编92121
电话18584500008
网址https://www.cibus.com/
公司代码CBUS
上市日期Jul 20, 2017
CEODr. Peter Ronald Beetham, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. August J. Moretti, J.D.
Mr. August J. Moretti, J.D.
Independent Director
Independent Director
--
--
Mr. Jean-Pierre Lehmann
Mr. Jean-Pierre Lehmann
Independent Director
Independent Director
--
--
Mr. Mark Finn
Mr. Mark Finn
Lead Independent Director
Lead Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
收入明细
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
暂无数据
地区USD
名称
营收
占比
United States
1.03M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Riggs (Rory B)
30.24%
Fidelity Management & Research Company LLC
9.50%
Armistice Capital LLC
4.03%
JPL Investments SA
3.46%
Vantage Consulting Group, Inc.
2.36%
Other
50.40%
持股股东
持股股东
占比
Riggs (Rory B)
30.24%
Fidelity Management & Research Company LLC
9.50%
Armistice Capital LLC
4.03%
JPL Investments SA
3.46%
Vantage Consulting Group, Inc.
2.36%
Other
50.40%
股东类型
持股股东
占比
Individual Investor
32.86%
Investment Advisor
14.99%
Investment Advisor/Hedge Fund
4.99%
Hedge Fund
4.12%
Corporation
3.55%
Family Office
0.44%
Research Firm
0.29%
Bank and Trust
0.09%
Other
38.69%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
166
29.51M
61.00%
+13.82M
2025Q1
171
17.83M
39.89%
+256.22K
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Riggs (Rory B)
14.63M
30.24%
+11.68M
+396.82%
Jun 09, 2025
Fidelity Management & Research Company LLC
4.60M
9.5%
+647.11K
+16.38%
Mar 31, 2025
Armistice Capital LLC
1.95M
4.03%
+1.95M
--
Mar 31, 2025
JPL Investments SA
1.67M
3.46%
-12.28K
-0.73%
Mar 24, 2025
Vantage Consulting Group, Inc.
1.14M
2.36%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.03M
2.13%
-16.63K
-1.59%
Mar 31, 2025
The Vanguard Group, Inc.
892.12K
1.84%
+41.63K
+4.90%
Mar 31, 2025
Geode Capital Management, L.L.C.
473.61K
0.98%
+81.22K
+20.70%
Mar 31, 2025
Beetham (Peter Ronald)
382.44K
0.79%
--
--
Mar 24, 2025
Gocal (Gregory Francis William)
374.84K
0.77%
+60.00K
+19.06%
Mar 24, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
占比0.01%
iShares Russell 2000 Value ETF
占比0%
Global X Russell 2000 ETF
占比0%
Proshares Ultra Russell 2000
占比0%
ProShares UltraPro Russell2000
占比0%
ProShares Hedge Replication ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
iShares Russell 2000 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
